One-Stop-Shop Genome Editing Product Launched by Inscripta®
Inscripta launches a fully automated, benchtop, CRISPR-mediated, genome engineering platform
Read More
Gene Whiz!
Boulder biotech companies are putting Colorado on the map for gene-editing breakthroughs
Read More
Gene editing reborn: A conversation with Inscripta®’s Richard Fox
Richard Fox might be the world’s ultimate power user in computational biology, and when he heard about Inscripta’s new technology,...
Read More
Biology Driving Big Changes to Global Economy
Kevin Ness, CEO at Inscripta, on human genomics and the business of gene editing. Hosted by Carol Massar and Jason...
Read More
Top 10 Companies Leveraging Gene Editing in 2019
In June at the 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) conference in New York City, Inscripta publicly presented...
Read More
Accelerating Forward Engineering at Genome Scale
Harnessing the power of biology to create products of commercial and scientific value is a challenging problem. The goal of...
Read More
Single Cell Writing May Unlock CRISPR’s Full Potential
After over three years of super stealth mode, Inscripta gave its first public presentation today at the 2019 Synthetic Biology:...
Read More
Inscripta® Looks to Combine CRISPR, Single-Cell Genomics, Synthetic Biology in New Platform
Kevin Ness, the CEO of gene editing company Inscripta, has long had a vision of doing for genome writing what...
Read More
Inscripta®’s MAD7™ Named a Top Innovation of 2018 by The Scientist
The award recognizes products that are set to revolutionize research and advance scientific knowledge
Read More
Inscripta® Wins Rising Star Award from Colorado BioScience Association
Inscripta has been selected for the Colorado BioScience Association’s 2018 Rising Star Award
Read More